Kymera Therapeutics
Nichole O'Connell is a seasoned professional in the field of biochemistry and biophysics, currently serving as the Director and Head of Platform Discovery at Kymera Therapeutics since November 2019. O'Connell has held positions of increasing responsibility in various companies, including Senior Scientist at Cedilla Therapeutics and Scientist II at Nurix, Inc. Previous experience includes roles as Senior Scientist in Biophysics at AstraZeneca and Postdoctoral Research Associate at both AstraZeneca and Brown University. Academic credentials include a Ph.D. in Biochemistry, Biophysics, and Molecular Biology from Columbia University, supplemented by a dual Bachelor's degree in Physics and Applied Mathematics from the University of Rhode Island.
This person is not in the org chart
This person is not in any teams
Kymera Therapeutics
6 followers
Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.